If you missed the ASIPP Virtual Annual Meeting on September 4-6, you may still view the on-demand version. Discounted pricing is available for those who attended the live virtual meeting. Recorded sessions for this meeting are not eligible for CME credits.

Recorded versions of our virtual review courses are available to purchase. The following courses are offered:

Attendees Price
New Registration
Imaging Review Course$ 100$ 300
Controlled Substance Management$ 100$ 300
Documentation, Coding, Compliance, and Practice Management$ 100$ 300
Board Review Course$ 200$ 500


The California Society of Interventional Pain Physicians is providing a unique, townhall type webinar on health policy and advocacy of both state and national issues that are of interest to CALSIPP members as well as pain physicians across the country.

The webinar is intended to provide discussion and different perspectives from experts. Following each session there will be a brief question and answer period that will bring additional viewpoints from attendees.

We will discuss the benefits of monitoring and auditing as related to in-person EM encounters and forecasting revenue changes in 2021 as well as telemedicine visits.
Documentation of medical necessity remains an area requiring ongoing focus by means of education and training to match the ever-changing payer regulations. Other topics include recent reports related to facet procedures and, of course, urine drug testing documentation and the relationship of these issues to ongoing monitoring of auditing. 




ASIPP this week sent seven comment letters to the following insurance providers regarding proposed rules that would hinder access of facet joint injections to patients. Click on the links below to read each letter.

CGS Administrators, LLC
First Coast Service Options, Inc.
National Government Services
Novitas Solutions, Inc.
Noridian Healthcare Solutions, LLC
Palmetto, GBA
Wisconsin Physician Services Insurance Corporation

Amniotic Tissue Intraarticular Injections

Many ASIPP members have recently been approached by sales representatives claiming that amniotic or umbilical cord tissue products are now covered by Medicare and many private insurers for intraarticular injections and interventional pain management procedures.

Based on collective evidence, unfortunately, these claims appear to be INACCURATE, subjecting patients and providers to high risk.

Amnion is covered for limited cutaneous wound healing applications and for a handful of neurosurgical and ophthalmic surgical uses, it has a product reimbursement code (also known as a Q code). If a physician submits the right combination of ICD-10 and CPT codes, Medicare may pay these claims.

Based on review of Medicare local coverage determination (LCD) documents, biologics for intraarticular injections and interventional pain management procedures are Experimental and Investigational. Hence, there is NO coverage for these products for intraarticular injections and interventional pain management procedures. 

It’s the recommendation of ASIPP that you avoid billing Medicare and private insurance for these products when used to treat orthopedic and pain management conditions. Our concern is that by billing these products to a federal program like Medicare, not only could there be significant Medicare clawbacks, but knowingly billing Medicare for products that you know are not covered can result in serious criminal penalties. Even, initial losses could be extensive.

For additional information on coverage guidelines from many private insurers that state that these products are NOT covered, experimental and investigational. Please check the websites of commercial carriers.

Last week ASIPP and SIPMS sent two comment letters to CMS – one on the 2021 Physician Fee Schedule and the other addressing the ASC &HOPD 2021 Fee Schedule.

Comment letter to CMS on physician payment proposed rule for 2021

Comment letter to CMS on ASC and HOPD proposed payment rates for 2021


Pain Physician, the official journal of ASIPP, has launched a special issue covering COVID-19 issues. The publications range from understanding the pathophysiological mechanisms, epidemiology, implications on interventional pain practices, safety and effectiveness of various modalities of drug therapy, telemedicine, along with the effect on interventional pain management practices, and, finally, the technological impact of COVID-19 on the future of education and health care delivery and multiple guidelines.

Pain Physician published COVID-19 special issue with 18 original manuscripts and multiple letters. This issue includes an amazing editorial [ ]; 

Evidence-Based Risk Mitigation Strategies and Stratification during COVID-19 for Return to Interventional Pain Practices [ ], and Triaging Interventional Pain Procedures during COVID-19 or Related Elective Surgery Restrictions [ ]. 

Both manuscripts describe various means to continuation of the services at present, and also in future if there is a resurgence or in a worst-case scenario lock-down, and training and education during COVID epidemic. Other articles include Burnout among Pain Physicians, Implications on Interventional Pain Practice, and manuscripts on antibody testing, drug therapy, and stem cell therapy.


As you know, ASIPP has been in the forefront and continuing our advocacy to make telehealth permanent for all insurers and all payers. In addition, we have also been trying to keep telephone only at the same price as face-to-face or telehealth visits…

On behalf of ASIPP, we would like to remind members of additional financing, SBA disaster loan options, and the Employee Retention Credit Programs designed for economic relief for practices/businesses suffering economic losses from Covid-19. For those who may feel the PPP Loans/Medicare Advanced Payments are not enough to fund operations through the crisis, there is another SBA program that could help you.


There have been numerous changes since the CDC guidelines were first published. During this time, HHS Inter-Agency Task Force developed Pain Management Best Practices: Updates, Gaps, Inconsistencies, and Recommendations. This is an excellent document with significant importance to interventional pain management.


Manchikanti and 37 distinguished co-authors from multiple institutions have published “Comprehensive Evidence-based Guidelines for Facet Joint Interventions in Management of Chronic Spinal Pain


We received a letter from Tracy Richardson, Acting Director, Financial Services Group, Office of Financial Management, Centers for Medicare And Medicaid Services, addressed to ASIPP in reference to confirming their position on telehealth and duration of waivers.


Updated News on Stimulus, Telehealth, CAC Meeting, and Guidelines


The following is important information on the newly released 2020 payment rules. ASIPP and SIPMS will be sending comment letters to CMS in the near future. You may also send comment letters to them on these payment rules.



Doctor Finder allows you to search for an ASIPP® Member Interventional Pain Physician anywhere in America by name or by location. It’s quick and easy.

PainExam is proud to announce that it now offers preparation for the ABIPP Pain Management Board Exam! In addition, PainExam has now collaborated with ASIPP to offer Virtual Learning programs.


PainCast, the pain management network, has collected years worth of information on the history and processes of the pain management specialization and transformed it into a virtual library of videos, journals, articles, podcasts, and more – all at your fingertips.

A Second Wave of Coronavirus (4-23-20) Neil Cavuto and Dr. Devi Nampiaparampil discuss a possible second wave of coronavirus this winter.


Essentials of Regenerative Medicine in Interventional Pain Management is a book to bring concise, collective, and comprehensive information to interventional pain physicians practicing regenerative medicine with its applications in managing chronic pain.


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value added services for the independent physician.


The American Society of Interventional Pain Physicians (ASIPP) is pleased to announce a partnership with Willow Risk Advisors to create an exclusive policy available to ASIPP members. In an effort to further increase value to its physician members, the American Society of Interventional Pain Physicians (ASIPP) has endorsed Willow Risk Advisors as their professional liability insurance broker.


ASIPP is now offering our members the benefit of a unique revenue cycle management/billing service. We have received a tremendous amount of interest in the ASIPP billing and coding program.